Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.81−0.00 (-0.17%)
Close on Nov 12, 2026Market cap $9.43MP/E –Yield –
Phio Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Phio Pharmaceuticals's enterprise value was -$3.55M on Nov 11, 2026, against -$3.42M a year earlier. Over the last 5 years it ranged from -$14.69M to $1.12M, with a median of -$5.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.55M | – |
| 2025 | Dec 31, 2025 | -$4.63M | – |
| 2024 | Dec 31, 2024 | -$3.67M | – |
| 2023 | Dec 29, 2023 | -$6.65M | – |
| 2022 | Dec 30, 2022 | -$9.40M | – |
| 2021 | Dec 31, 2021 | -$12.99M | – |
| 2020 | Dec 31, 2020 | -$1.14M | – |
| 2019 | Dec 31, 2019 | -$4.37M | – |
| 2018 | Dec 31, 2018 | -$1.82M | -123.6% |
| 2017 | Dec 29, 2017 | $7.71M | +230.3% |
| 2016 | Dec 30, 2016 | $2.33M | -81.6% |
| 2015 | Dec 31, 2015 | $12.70M | -47.3% |
| 2014 | Dec 31, 2014 | $24.08M | +29.5% |
| 2013 | Dec 31, 2013 | $18.61M | +968.6% |
| 2012 | Dec 31, 2012 | $1.74M | – |
See a number that looks wrong?